September 29-30, 2023 | Friday-Saturday
As valvular heart disease and structural heart treatments become more integral within cardiology, providers will rely on the diagnosis and treatment of disease using transcatheter/nonsurgical therapy.
The 40th Annual Echocardiography and Structural Heart Symposium will include important topics that focus on current guidelines for the evaluation of core issues within echocardiography, such as cardiac structure, cardiac function and hemodynamics assessment.
In addition, the internationally renowned faculty experts will address the latest developments, cutting-edge technologies and future directions of structural heart disease assessment, treatment options and advanced cardiac imaging.
These discussions will include advanced echocardiography imaging techniques (3-D, Strain, CT and TEE) and valve repair approaches (TAVR, Transcatheter Edge-to-Edge Repair (TEER), left atrial appendage occlusion devices, paravalvular closure and alcohol septal ablation). Treatment focus will be on aortic, mitral and tricuspid valves and interatrial septum valvular heart disease, as well as specific patient populations, including those with cancer, atrial fibrillation, valvular heart disease and hypertrophic cardiomyopathy. Current controversies speak to indications and contraindications for various diagnostic and treatment approaches.
This year’s expanded focus will be of special interest to sonographers, anesthesiologists, cardiologists, ED physicians, critical care physicians and medical professionals interested in echocardiography and the newest advances in the diagnosis and treatment of structural heart disease.
MORE INFORMATION AND REGISTER >>